Agenda item
Plymouth Drugs Strategy Partnership Annual Report 2024
Minutes:
Kamal Patel (Consultant, Public Health) delivered the Plymouth Drugs Strategy Partnership Annual Report 2024 to the Board, and discussed:
a) Common risk factors and lived experiences of those engaging with drug and alcohol services;
b) The role of the national drugs strategy ‘From Harm to Hope’;
c) Funding and programme delivery through the Plymouth Complex Lives Alliance;
d) The interconnected benefits and cost efficiency of drug and alcohol services for homelessness, employment, crime, drug supply, antisocial behaviour, equalities, and other factors;
e) Unique drug use patterns and demographics for Plymouth;
f) A significant increase in the demand for these services during 2023;
g) Drug related deaths and national comparators;
h) Workforce training and recruitment, including the introduction of the Rapid Access to Prescribing Team and Overdose Response Team;
i) The optimisation of Opiate substitution doses;
j) Increased capacity enabled through grant funding, which was now expected to remain stable following three yearly incremental increases;
k) The development of the Local Drug Information System to facilitate reporting and intelligence dissemination of contaminated / dangerously higher potency drug batches;
l) The establishment of a partnership with Bath University to rapidly test drug samples;
m) The improvement of Naloxone distribution around the city, which was vital in the event of drug overdoses;
n) The development of the ‘Avoidable Deaths Approach’ to facilitate learning and improvements from drug and alcohol related deaths;
o) Improvements to the referral process for drug and alcohol services.
In response to questions, the Board discussed:
p) Links between city-wide work to reduce inequalities, the ‘trauma informed approach’, mental health support, early support and intervention, and prevention of drug use;
q) Generational drug use and Plymouth’s demographics;
r) Grant funding for Drug and Alcohol services, and risks regarding long-term sustainability;
The Board agreed to note the report.
Supporting documents:
- HWBB Report Plymouth Drugs Strategic Partnership- Cover Sheet, item 7. PDF 166 KB
- Plymouth Drugs Strategy Partnership - Annual Report 2024, item 7. PDF 315 KB
- Plymouth Drugs Strategic Partnership Annual Report 2024 - Presentation, item 7. PDF 274 KB